Nav: Home

Current Lung cancer News and Events

Current Lung cancer News and Events, Lung cancer News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Cancer cells turn to cannibalism to survive chemotherapy, study suggests
Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells. (2019-09-17)
Electronic nose can sniff out which lung cancer patients will respond to immunotherapy
An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research published in the leading cancer journal Annals of Oncology. (2019-09-17)
Subgroup of colorectal cancer patients ID'd: Do poorly, could benefit from immunotherapy
While the medical community agrees immune cells inside a tumor leads to improved health outcome, for a subset of colorectal cancer patients, having too much of a good thing is a strong predictor of disease recurrence and reduced chances of survival. (2019-09-16)
Just bad luck? Cancer patients nominate 'fate' as third most likely cause
What role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia and 125,000 people in Vietnam? (2019-09-15)
Same but different: unique cancer traits key to targeted therapies
Melbourne researchers have discovered that the key to personalised therapies for some types of lung cancers may be to focus on their differences, not their similarities. (2019-09-13)
Machine learning improves the diagnosis of patients with head and neck cancers
Researchers from Charité - Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the diagnosis of head and neck cancers. (2019-09-12)
Patients diagnosed with cancer after skipping appointment more likely to die within a year
Cancer patients who miss an urgent referral appointment for their symptoms are 12% more likely to die within 12 months of diagnosis, a major new study has found. (2019-09-12)
Scientists discover new breakthrough in cancer hair loss treatment
Researchers based at The University of Manchester have discovered a new strategy for how to protect hair follicles from chemotherapy, which could lead to new treatments that prevent chemotherapy-induced hair loss -- arguably one of the most psychologically distressing side effects of modern cancer therapy. (2019-09-12)
Markey researchers discover role of nuclear glycogen in non-small cell lung cancers
Researchers at the University of Kentucky Markey Cancer Center have made a breakthrough discovery that solves a mystery long forgotten by science and have identified a potentially novel avenue in pre-clinical models to treat non-small cell lung cancers. (2019-09-12)
Some cancer drugs in clinical trials don't work by hitting their targets
Multiple cancer drug candidates in clinical trials kill tumor cells through off-target effects instead of by interacting with their intended molecular targets, according to a new study. (2019-09-11)
UK improves cancer survival, but is still behind other high-income countries
Cancer survival in the UK has improved since 1995, although it still lags behind other high-income countries, according to new analysis by the International Cancer Benchmarking Partnership (ICBP), which is managed by Cancer Research UK. (2019-09-11)
IMpower131
Patients with Stage IV squamous non-small cell lung cancer enrolled in clinical trial to test the immunotherapy atezolizumab and chemotherapy against chemotherapy alone experienced a longer survival rate, among a subgroup of patients with high PD-LI. (2019-09-10)
Europeans face significant challenges to participate in lung cancer clinical trials
A survey of patients with lung cancer in several European countries revealed that half did not know what a cancer clinical trial is, and 22% had never heard of a cancer clinical trial. (2019-09-10)
KEYNOTE-024 three-year survival update
First line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. (2019-09-10)
Nurse led follow-up service aids patients with respected early stage lung cancer, improves clinic efficiency
The presence of the specialist nurse within thoracic surgical centers in the United Kingdom increased clinic capacity and efficiency, reduced waiting time for appointments, promoted junior medical training and ensured continuity of care for the patients, according to an analysis reported today by Jenny Mitchell from Oxford University Hospitals NHS Foundation Trust, in Oxford, United Kingdom. (2019-09-10)
Patients taking nivolumab experience five-fold increase in overall survival compared to chemotherapy
Pooled data on two clinical trials demonstrate patients taking nivolumab realized a greater than five-fold increase in five-year overall survival rate compared with the chemotherapy docetaxel. (2019-09-10)
Gene coding error found in rare, inherited gene cof lung-scarring disorder linked to short telomeres
By combing through the entire genetic sequences of a person with a lung scarring disease and 13 of the person's relatives, Johns Hopkins Medicine researchers say they have found a coding error in a single gene that is likely responsible for a rare form of the disease and the abnormally short protective DNA caps on chromosomes long associated with it. (2019-09-10)
Factors associated with longer wait times in colorectal cancer specialty care referrals
Delay in referral to specialty care for patients who have symptoms of colorectal cancer may lead to poor health outcomes. (2019-09-09)
Registrational data from LIBRETTO-001 trial
Selpercatinib was granted Breakthrough Therapy Designation by the US Food & Drug Administration in 2018 after initial data from the clinical trial LOXO-292 Investigated to Block RET-altered Tumors (LIBRETTO-001) showed the therapy demonstrated robust anti-tumor activity in a group of RET fusion-positive non small cell lung cancer patients, as well as strong evidence of durability. (2019-09-09)
National lung matrix trial (NLMT)
The largest stratified medicine dataset of non-small cell lung cancer patients indicates further molecular stratifications could benefit from targeted therapies, according to research presented today at the IASLC 2019 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer. (2019-09-09)
Scottish study shows that autoantibody test followed by CT imaging may reduce lung cancer mortality
A combination of the EarlyCDT-Lung Test followed by CT imaging in Scottish patients at risk for lung cancer resulted in a significant decrease in late stage diagnosis of lung cancer and may decrease lung cancer specific mortality, according to research presented at IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer (IASLC). (2019-09-09)
Video assisted lung surgery reduces complications and hospital stays compared to open surgery
Video-assisted thoracic surgery is associated with lower in-hospital complications and shorter length of stay compared with open surgery among British patients who were diagnosed at an early stage of lung cancer, according to research presented today the IASLC 2019 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer. (2019-09-09)
Durvalumab combined with chemotherapy improves overall survival in patients with lung cancer
Adding immunotherapy in the form of durvalumab to chemotherapy improves overall survival in patients with extensive-stage small cell lung cancer, according to research presented today at the IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer (IASLC). (2019-09-09)
Major gaps exist in patient understanding of genomic test results, Lung-MAP study shows
A majority of cancer patients don't understand key aspects of the genomic test results they receive as participants in biomarker-driven clinical trials, according to a first-of-its-kind pilot study conducted under the Lung Cancer Master Protocol (Lung-MAP). (2019-09-09)
Blood test shows promise to aid better detection of lung cancer
Lung cancer can be spotted earlier and diagnosed more precisely with the help of a blood test. (2019-09-09)
Precious metal flecks could be catalyst for better cancer therapies
Tiny extracts of a precious metal used widely in industry could play a vital role in new cancer therapies. (2019-09-09)
Lung cancer screening model favored in Europe detects more cancers than 1 preferred in the US
Researchers reported today that a prospective trial comparing 2 screening methods for at-risk lung cancer patients found that a model used by Canadian, Australian and European public health organizations detected more cancers than the screening model used by the United States Preventive Services Task Force (USPSTF). (2019-09-09)
BioMILD trial demonstrates lung cancer screening using MicroRNA blood test enhances prevention
Lung cancer screening efforts have accelerated in the last decade, with researchers showing that low dose CT screening is effective in reducing lung cancer mortality. (2019-09-09)
Study supports germline testing for all metastatic breast cancer patients
Genetic testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies, according to research published in JAMA Oncology. (2019-09-09)
New KEYNOTE 021 data shows no association with tumor mutational burden
Researchers had previously reported data from the KEYNOTE 021 trial that showed antitumor activity for pembrolizumab plus platinum-based chemotherapy in untreated advanced nonsquamous non-small cell lung cancer patients. (2019-09-08)
Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients
Combining the PD-1 immune check point inhibitor nivolumab with the monoclonal antibody ipilimumab showed a consistent safety profile in special populations with advanced non-small cell lung cancer (NSCLC), according to research presented today by at the IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer. (2019-09-08)
Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer
A clinical trial testing the toxicity of a KRAS inhibitor demonstrated early promising antitumor activity and few adverse side effects in patients with advanced non-small cell lung cancer harboring KRAS G12C mutation, according to research presented today at the IASLC 2019 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer. (2019-09-08)
Keynote 189: Tumor mutational burden not significantly associated with efficacy of pembrolizumab
Tumor mutational burden was not significantly associated with efficacy of pembrolizumab plus chemotherapy or placebo plus chemotherapy as first-line therapy for metastatic nonsquamous non-small cell lung cancer, according to research reported today by Dr. (2019-09-08)
BioMILD trial demonstrates lung cancer screening using microrna blood test enhance prevention effort
Lung cancer screening efforts have accelerated in the last decade, with researchers showing that low dose CT screening is effective in reducing lung cancer mortality. (2019-09-08)
Mutations associated with sensitivity or resistance to immunotherapy in mNSCLC
The relationship between gene alterations and response to anti-PD-L1 with and without anti-CTLA-4 are not well characterized. (2019-09-08)
Analysis from the MYSTIC Trial
The relationship between gene alterations and response to An update from the Phase III MYSTIC study showed poorer outcomes across treatment arms in patients with metastatic non-small cell lung cancer and mutations in STK11 or KEAP1 genes compared with those without the corresponding mutations. (2019-09-08)
Tobacco cessation after cancer diagnosis: Declaration from the IASLC
The International Association for the Study of Lung Cancer today used the platform of its largest international meeting to call attention to the importance of tobacco cessation after cancer diagnosis, and urged all physicians to screen cancer patients for tobacco use and recommend tobacco cessation. (2019-09-07)
Eating mushrooms may help lower prostate cancer risk
A new study published in the International Journal of Cancer found an inverse relationship between mushroom consumption and the development of prostate cancer among middle-aged and elderly Japanese men, suggesting that regular mushroom intake might help to prevent prostate cancer. (2019-09-05)
Obesity and psychosocial well-being among patients with cancer
In a study published in Psycho-Oncology, excess weight was linked with poorer psychosocial health among older adults diagnosed with breast cancer or prostate cancer. (2019-09-05)
Researchers characterize lung inflammation associated with some cancer immnunotherapy
Immune checkpoint inhibitors uses the immune system to fight cancer. (2019-09-05)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...